Nicolas Folschweiller

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

Vianney Tricou, Delia Yu, Humberto Reynales et al. · The Lancet Global Health · 2024 · 225 citations · Full text

Veterinary Medicine, Child Health, Infectious Diseases +17

The Crystal Structure of the Pyoverdine Outer Membrane Receptor FpvA from Pseudomonas aeruginosa at 3.6Å Resolution

David Cobessi, Hervé Celia, Nicolas Folschweiller et al. · Journal of Molecular Biology · 2005 · 184 citations

Life Sciences, Biophysics, Microbiology +15

Ten‐year immune persistence and safety of the <scp>HPV</scp>‐16/18 <scp>AS</scp>04‐adjuvanted vaccine in females vaccinated at 15–55 years of age

Tino F. Schwarz, Marek Spaczyński, Jacek Wysocki et al. · Cancer Medicine · 2017 · 70 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Characterization of 16 human G protein-coupled receptors expressed in baculovirus-infected insect cells

Malika Akermoun, Markus Koglin, Darina Zvalova-Iooss et al. · Protein Expression and Purification · 2005 · 65 citations

Life Sciences, Entomology, Molecular Biology +11

The Interaction between Pyoverdin and Its Outer Membrane Receptor in <i>Pseudomonas aeruginosa </i>Leads to Different Conformers:  A Time-Resolved Fluorescence Study

Nicolas Folschweiller, Jacques Gallay, Michel Vincent et al. · Biochemistry · 2002 · 57 citations

Life Sciences, Biochemistry, Microbiology +17